CVB homepage

Trending
Death after TAVR: New data support use of better patient assessments
TAVR concerns: Cardiologists, patient family members question quality of care at rural hospital
Exploring the pros and cons of direct-to-patient drug programs
PAD patients minimize risk when they listen to their doctors
ACC-AHA release first cardiovascular-kidney-metabolic syndrome guidelines
the words "FDA recall" on a board
Medline recalls nearly 50K procedure kits, including many used by cardiologists

This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.

An example of the image quality from the new GE Photonova photon-counting CT system, where more detailed images of soft plaque and the ability to see through heavy calcium and stents is expected to improve CT-FFR assessments.
Looking ahead to the future of FFR-CT

Current research suggests this technology is just getting started when it comes to transforming patient care.

business partnership handshake merger acquisition M&A
Medtronic completes $550M acquisition of neurovascular company

Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic. 

Ziad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute, St. Francis Hospital and Heart Center, spoke with Cardiovascular Business about his center's experience using the recently released Johnson & Johnson MedTech next-generation Shockwave C2 Aero Coronary IVL Catheter to treat calcified coronary artery disease. Ali said his center was the first in the world to use the catheter in August 2025 and has since gained experience in roughly 80 cases.
Shockwave Medical's new IVL catheter overcomes previous limitations

Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. 

Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
SMART update: Self-expanding TAVR valves still linked to superior durability after 3 years

These three-year data represent a major update to one of the more noteworthy TAVR trials in recent memory.

Video: Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, Icahn School of Medicine at Mount Sinai, explains studies on the latest pulsed field ablation and leadless conduction pacing trials. #PFA #conductionpacing
Exploring the latest data in PFA and leadless conduction system pacing

Vivek Reddy, MD, spoke to Cardiovascular Business about some of the biggest trends in electrophysiology today.

Boston Scientific’s Seismiq 4CE Coronary IVL Catheter
More good news for Boston Scientific’s coronary IVL tech

Late-breaking data out of EuroPCR focused on 420 patients treated with Boston Scientific's new coronary IVL catheter. Overall, the device was found to be both safe and effective for patients with severe CAD.

How aldosterone works to treat hypertension.
FDA approves first-in-class hypertension drug from AstraZeneca

Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.

Samuel Jones, MD, MPH, director of inpatient electrophysiology at the Memorial Hospital, Chattanooga Heart Institute, discusses concerns over new heart failure Medicare Ambulatory Specialty Model payment model that starts on Jan. 1, 2027.
Cardiologists scramble to prepare for mandatory heart failure payment model

Samuel Jones, MD, reviews some of the biggest concerns about a new Medicare payment model focused on heart failure care that goes live in 2027. 

Innovation at work

Cardiovascular Business
Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.  

In cooperation with CareDx

Around the web

Radiology Business
Radiology group sues hospital claiming it waged ‘retaliatory campaign’ after contract talks fell apart
Radiology Business
Class action lawsuit claims radiology vendor Nano-X Imaging misled investors
Radiology Business
Radiology Partners affiliate inks in-network deal with Anthem Blue Cross